Tarus Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://tarustx.com
TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors
Phase 1
Withdrawn
- Conditions
- Colorectal CancerGastric CancerHepatocellular CarcinomaPancreatic Cancer
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Tarus Therapeutics, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT04976660
© Copyright 2025. All Rights Reserved by MedPath